Cargando…
Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond
Heart failure remains a major concern across the globe as life expectancies and delivery of health care continue to improve. There has been a dearth of new developments in heart failure therapies in the last decade until last year, with the release of the results from the PARADIGM-HF Trial heralding...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459540/ https://www.ncbi.nlm.nih.gov/pubmed/26082640 http://dx.doi.org/10.2147/VHRM.S55630 |